Biond Biologics
PrivateLast Round
Strategic
Jun 1, 2026
Total Funding Raised
$40M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Biond Biologics operates in Healthcare & Life Sciences and is based in Israel. Its latest recorded funding round was a Strategic round in June 2026.
Biond Biologics is a biotechnology company that develops first-in-class immunotherapies for the treatment of cancer and immune-mediated diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Revenue Share
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Biond Biologics Comparables
Compare Biond Biologics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Ascendo Biotechnology | 81% | |
| Tizona Therapeutics | 80% | |
| Compugen Ltd. | 79% |
For institutional investors. Book with your work email.
Biond Biologics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Strategic | Jun 1, 2026 | ||||
| Series C | Nov 3, 2021 | ||||
| Series B | Jan 8, 2019 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Biond Biologics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Israel Biotech Fund | Series B |
| Deep Insight | Series C |
| The Heritage Group | Series C |
| SBI JI | Series B |
| Harel Insurance Investments & Financial Services | Series C, Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 1, 2026
Raised $8M in a strategic round.
- Nov 3, 2021
$15M round led by Deep Insight.
For institutional investors. Book with your work email.
Biond Biologics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Biond Biologics's valuation, stock price, and market status.
Is Biond Biologics a public or private company?
Biond Biologics is a private company.
What is the current stock price of Biond Biologics?
Biond Biologics is a private company, so its shares have no public market price. Caplight tracks Biond Biologics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Biond Biologics worth (valuation)?
Valuation information for Biond Biologics is not publicly available.
Can I buy Biond Biologics stock?
Biond Biologics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Biond Biologics's last funding round?
Biond Biologics's most recent funding round was Strategic on June 1, 2026.
Who are the main investors in Biond Biologics?
Key investors in Biond Biologics include Israel Biotech Fund, Deep Insight, Harel Insurance Investments & Financial Services.
Will Biond Biologics IPO soon?
No public IPO plans have been announced for Biond Biologics.
How can I track Biond Biologics secondary market activity?
Caplight tracks bids, offers, and trades in Biond Biologics's shares on secondary markets.